IP and R&D Spark Newsletter

This month’s edition continues our 2026 theme of “Signal → Scale,” highlighting how policy support, international cooperation, and maturing technologies are accelerating real-world adoption.

In Industry News, India launches ICMR’s “Patent Mitra” to strengthen biomedical patenting and technology transfer, while the EPO–IP Australia PCT pilot offers Australian applicants a faster pathway into Europe. WIPO’s Shanghai ADR Hub crosses 200 foreign-related IP disputes with rising court referrals, underscoring the growing role of alternative dispute resolution. Meanwhile, Korea and China deepen IP cooperation to combat counterfeits and curb bad-faith filings.

This month’s Techno Spotlight captures breakthroughs translating into scalable impact across sectors.

• Chemicals & Materials: Innovations turn CO₂ into valuable fuels and chemicals, uncover algae-inspired solar protection, and introduce new devices that upcycle carbon emissions—alongside strategic M&A shaping clean-tech trajectories.
• Life Sciences: Advances range from overcoming resistance in pancreatic cancer and AI-driven molecular design (PropMolFlow) to skin-interfaced cortisol monitoring wearables and stem cell therapies moving closer to functional cures.
• Hi-Tech: Highlights include wearable ultrasound for elderly care, terahertz microscopy revealing superconducting electron motion, efficient cooling for scalable trapped-ion quantum computing, and heat-based computing for ultra-efficient sensing.
• Consumer Goods: AI and digital twins enter the mainstream as PepsiCo partners with Siemens and NVIDIA, Clorox acquires GOJO (Purell®), Amway Korea launches AI-powered wellness personalization, and collagen-infused functional dairy debuts in Spain.
• Chemical Safety & Regulatory Affairs: Regulators emphasize smarter, faster pathways—FDA/EMA approvals show rare-disease and biosimilar momentum, FDA signals CMC flexibility for cell & gene therapies, Japan moves to ban PFHxS chemicals, and ECHA’s OSOA upgrade promises faster EU risk decisions. Draft guidance on Bayesian evidence borrowing and CBER’s 2026 roadmap point to modernized clinical development.
• Automobile, e-mobility & Mechanical: Automakers balance legacy and future—Volkswagen commits to gasoline hot hatches, BMW retains big engines (even the V12) while rolling out a new brand identity, and China explores partnerships to navigate European tariffs.
• Standard Essential Patents: Licensing momentum builds as Sisvel launches a Wi-Fi multimode SEP pool, Nokia–Hisense settle with a multi-year video license, InterDigital & Sony sign a multi-tech deal with LG, and OPPO joins the VVC Advance pool while extending its HEVC license.

Together, these stories highlight how innovation is moving beyond proof-of-concept, as collaboration, regulation, and technology come together to enable real-world adoption.

Stay tuned for more innovation shaping the IP and R&D landscape!